Ioannis Serafimidis

Developmental Biologist with special interest in adult tissue stem cells, pancreas regeneration and cancer. Group leader at the Academy of Athens.

[Frontiers - Endocrinology @FrontEndocrinol]

New Research: Editorial: Mechanisms of endocrine cell proliferation in the embryonic, neonatal and adult pancreas https://t.co/PMweNbEJgi #FrontiersIn #Endocrinology

[Ioannis Serafimidis @ISerafimidis]

https://t.co/oz6IDzBd9B #brfaa #kras #lungcancer

[Ioannis Serafimidis @ISerafimidis]

The first preprint from our lab is out now!!!

[bioRxiv Cell Biology @biorxiv_cellbio]

Pharmacological targeting of SOS1-RAS interaction triggers pancreatic β-cell proliferation and sustainably reverses diabetic ... https://t.co/XXJL3KsGbb #biorxiv_cellbio

[Scientific American @sciam]

Physicists showed that photons can seem to exit a material before entering it, revealing observational evidence of negative time https://t.co/zzuIgV6gGq

[Abrous Lab @abrous_lab]

For #Eurogenesis2024, we really wanted to bring young talented scientists from all over the world 🌎 That's why together with our partners @bosn_journal & @MnSociety, 7 travel grants were awarded! Here are some pictures & the full list of awardees below 👇 Congratulations!! 👏🤩

[Santiago Rodríguez Seguí @RSeguiLab]

We've just launched a new Research Topic on "Advances in β-cell Development & Regeneration" in @FrontiersIn! Co-edited by @TxellRovira, @GittesGeorge and myself, we are now receiving manuscript proposals. Explore and contribute your insights!

More info: https://t.co/FW7C5AIut8

[Oded Rechavi @OdedRechavi]

Being a scientist is amazing - one moment you're having a brilliant idea and BOOM! 10 years and 1 million $ later it's published in a journal

[reNEW @reNEW_Global]

It is with great sorrow that we announce the loss of our dear friend, colleague, and mentor, Palle Serup.

https://t.co/JNS3igWKKP

[Ioannis Serafimidis @ISerafimidis]

@LabSpagnoli @Dev_Cell @DarriJf @SalowkaAnna @KingsCollegeLon @KCLstemcells @KCLBMBioscience Beautiful work! Congratulations!

[Heiko Lickert @LickertHeiko]

Hmm, hope this is not a serious problem for the study. BTW, Vertex also cuts ties to CRISPR Therapeutics’ type 1 diabetes stem cell therapy using hypoimmune cells, related? @bhushanlab @OtonkoskiT @mcnostro @nictitate @msanderlab @HebrokLab @JimhnsonSci

[Boehringer Ingelheim @Boehringer]

#NEWS: Together with @EliLillyandCo we are happy to share that Jardiance® (empagliflozin) has received approval from the @EU_Commission for the treatment of children aged 10 years and above with #Type2Diabetes, following recent approval by the @US_FDA 👉 https://t.co/6CylHCe0oI

[Frontiers - Oncology @FrontOncology]

New research: Targeting autophagy in pancreatic cancer: The cancer stem cell perspective: Pancreatic cancer is currently the seventh leading cause of cancer-related deaths worldwide, with the estimated death toll approaching half a million… https://t.co/ymUmMXf8n9 #oncology

[Jean-Michel Jarre @jeanmicheljarre]

Dear Vangelis, 
We will all remember your unique touch and your moving melodies forever. 
You & I have always shared  the same passion for synthesizers and electronic music since so long…
May you Rest In Peace,
JMJ x

[Jeffrey Millman @JeffreyRMillman]

Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments https://t.co/7dbv6SGeML via @statnews

[European Islet Study Group Workshop 2022/06/13-15 @EISG_2022]

Present your data at EISG 2022: we have 10 open slots for short talks. ATTENTION abstract deadline for short talk selection: April 4th 2022.

[Robert Insall @robinsall]

Important news for @agow @hw1o9 @clathrin @philbertpauken - I have used Shannon entropy to calculate the worst possible first guess in a #Wordle game!

It's...

...drumroll...

... FUZZY

[Ioannis Serafimidis @ISerafimidis]

Wordle 210 3/6

⬛🟩⬛⬛⬛
⬛🟩⬛⬛⬛
🟩🟩🟩🟩🟩

[Ioannis Serafimidis @ISerafimidis]

Wordle 209 5/6

⬛🟩⬛⬛🟨
🟩🟩⬛⬛🟨
🟩🟩🟩🟩⬛
🟩🟩🟩🟩⬛
🟩🟩🟩🟩🟩

[Michael 英泉 Eisen @mbeisen]

The real tragedy of the $11,000 @NatureNeuro APC is that the vast majority of the people who have papers accepted there can afford it because “high impact” science is in too many circles synonymous with well funded science.

[Dr. Claire Morgan @claire_c_morgan]

Postdoc position available in the Ferrer lab. Please pass along to those interested in regulatory genomics and diabetes: https://t.co/HCcOty91g7